CA2130748A1 - Utilisation du facteur mitogenique plaquettaire (pdgf) pour accelerer la cicatrisation des lesions oculaires - Google Patents

Utilisation du facteur mitogenique plaquettaire (pdgf) pour accelerer la cicatrisation des lesions oculaires

Info

Publication number
CA2130748A1
CA2130748A1 CA002130748A CA2130748A CA2130748A1 CA 2130748 A1 CA2130748 A1 CA 2130748A1 CA 002130748 A CA002130748 A CA 002130748A CA 2130748 A CA2130748 A CA 2130748A CA 2130748 A1 CA2130748 A1 CA 2130748A1
Authority
CA
Canada
Prior art keywords
growth factor
platelet
derived growth
isoform
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002130748A
Other languages
English (en)
Inventor
Michael E. Stern
Larry A. Wheeler
Margery A. Nicolson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Allergan Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2130748A1 publication Critical patent/CA2130748A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002130748A 1992-02-26 1993-02-24 Utilisation du facteur mitogenique plaquettaire (pdgf) pour accelerer la cicatrisation des lesions oculaires Abandoned CA2130748A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84230692A 1992-02-26 1992-02-26
US07/842,306 1992-02-26

Publications (1)

Publication Number Publication Date
CA2130748A1 true CA2130748A1 (fr) 1993-09-02

Family

ID=25287025

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002130748A Abandoned CA2130748A1 (fr) 1992-02-26 1993-02-24 Utilisation du facteur mitogenique plaquettaire (pdgf) pour accelerer la cicatrisation des lesions oculaires

Country Status (6)

Country Link
US (1) US5863892A (fr)
EP (1) EP0639980A1 (fr)
JP (1) JPH07507055A (fr)
AU (1) AU670075B2 (fr)
CA (1) CA2130748A1 (fr)
WO (1) WO1993016719A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952304A (en) 1993-10-22 1999-09-14 Trigen Limited Platelet-derived growth factor analogues
WO1995011259A1 (fr) * 1993-10-22 1995-04-27 Ellerman Pharmaceuticals Limited Analogues du facteur de croissance derive de plaquettes
US7374678B2 (en) * 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US6905612B2 (en) * 2003-03-21 2005-06-14 Hanuman Llc Plasma concentrate apparatus and method
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7179391B2 (en) * 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
PL1848473T3 (pl) * 2005-02-07 2013-11-29 Hanuman Llc Urządzenie - koncentrator osocza
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8430813B2 (en) * 2006-05-26 2013-04-30 Depuy Spine, Inc. Illuminated surgical access system including a surgical access device and integrated light emitter
US7806276B2 (en) * 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2567692B1 (fr) 2008-02-27 2016-04-06 Biomet Biologics, LLC Utilisation d'un dispositif pour obtenir des solutions riches en antagoniste de récepteur d'interleukine-1
US8337711B2 (en) * 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) * 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) * 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
CN110312523B (zh) 2016-11-08 2024-04-26 齐鲁皮吉特湾生物治疗有限公司 抗pd1和抗ctla4抗体
PL240667B1 (pl) * 2018-03-26 2022-05-16 Gdanski Univ Medyczny Peptyd, będący fragmentem płytkopochodnego czynnika wzrostu do zastosowania jako środek leczniczy do podania na skórę w zaburzeniach naskórka do stymulacji odbudowy naskórka

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983580A (en) * 1986-04-04 1991-01-08 Allergan, Inc. Methods and materials for use in corneal wound healing
EP0339905A3 (fr) * 1988-04-25 1991-05-08 Ethicon, Inc. Composition cicatrisante contenant un facteur de croissance et des rétinoides
US5034375A (en) * 1988-08-10 1991-07-23 Institute Of Molecular Biology, Inc. Process of wound healing using PDGF and EGF
US4939135A (en) * 1988-10-03 1990-07-03 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
DE59005319D1 (de) * 1989-01-20 1994-05-19 Schumann Klaus Operationsnadel und verfahren zu ihrer herstellung.
US5272064A (en) * 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof

Also Published As

Publication number Publication date
AU670075B2 (en) 1996-07-04
EP0639980A1 (fr) 1995-03-01
WO1993016719A2 (fr) 1993-09-02
US5863892A (en) 1999-01-26
AU3779393A (en) 1993-09-13
JPH07507055A (ja) 1995-08-03
WO1993016719A3 (fr) 1993-10-28

Similar Documents

Publication Publication Date Title
CA2130748A1 (fr) Utilisation du facteur mitogenique plaquettaire (pdgf) pour accelerer la cicatrisation des lesions oculaires
AU646014B2 (en) Novel platelet-derived growth factor B chain analogs and method for homogeneous production thereof
EP0678522B1 (fr) Analogues d'insuline
US5304473A (en) A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
CA2159109C (fr) Utilisations therapeutiques du facteur de croissance des keratinocytes
EP0741188A2 (fr) Insuline monocaténaire avec bioactivité élevée
NO301775B1 (no) DNA-sekvens som koder for nye former av kolonistimulerende faktor-1, vektor, ekspresjonssystem og rekombinant vertscelle
US5547935A (en) Muteins of human epidermal growth factor exhibiting enhanced binding at low PH
US5705484A (en) Biologically active polypeptide fusion dimers
WO1990013570A1 (fr) Facteur de croissance epidermique humain a substitution en position 11
HUT57059A (en) Process for producing t-celle-suppressive factor
RU2344172C2 (ru) Мутеины плацентарного фактора роста 1 типа, способ их получения и применение
US5498600A (en) Biologically active mosaic proteins
JPH082309B2 (ja) 突然変異体の酸性繊維芽細胞成長因子
US5202428A (en) DNA encoding neurotropic growth factor
JP2990162B2 (ja) ヒト酸性線維芽細胞成長因子の組成物、その製法、ｄｎａ構築物および酵母宿主細胞
KR101671197B1 (ko) 글루타레독신 1 융합단백질을 함유하는 관절염 예방 및 치료용 약학 조성물
MXPA00005709A (en) Bone morphogenetic protein (bmp)-17 and bmp-18 compositions

Legal Events

Date Code Title Description
FZDE Discontinued